comparemela.com

Latest Breaking News On - Davidp luci - Page 10 : comparemela.com

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United-states
America
Robertg-shawah
Davidp-luci
Prnewswire-acurx-pharmaceuticals-inc
Trial-oversight-committee
Drug-administration
Society-or-healthcare-epidemiology-of-america
Nasdaq
Diseases-society-of-america
Acurx-pharmaceuticals

Acurx Announces First Patient Enrolled in Phase 2b Clinical Trial of its Lead Antibiotic for Treatment of Clostridioides difficile Infection (CDI)

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United-states
America
Robertj-deluccia
Davidp-luci
Centers-for-disease
Prnewswire-acurx-pharmaceuticals-inc
Trial-oversight-committee
Drug-administration
Society-or-healthcare-epidemiology-of-america
Nasdaq
Diseases-society-of-america

Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI at the 9th International C. diff. Conference

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United-states
America
Davidp-luci
Prnewswire-acurx-pharmaceuticals-inc
Trial-oversight-committee
Drug-administration
Society-or-healthcare-epidemiology-of-america
Us-centers-for-disease
Conference-health-expo
Nasdaq
University-of-houston-college-pharmacy

Acurx Pharmaceuticals to Discuss 2021 Third Quarter Financial Results on November 15, 2021 Conference Call and Provide Business Update

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

Robertg-shawah
Davidp-luci
Acurx-pharmaceuticals-inc
Acurx-pharmaceuticals
Drug-administration
Nasdaq
Chief-executive-officer
Chief-financial-officer
Gram-positive-selective-spectrum
Qualified-infectious-disease-product
Generating-new-antibiotic-incentives-now

Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI in a Scientific Poster Presentation at IDWeek 2021 Conference

Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI in a Scientific Poster Presentation at IDWeek 2021 Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Davidp-luci
Kevin-garey
Trial-oversight-committee
Drug-administration
Society-or-healthcare-epidemiology-of-america
Nasdaq
Acurx-pharmaceuticals
Acurx-pharmaceuticals-inc
Infectious-diseases-society-of-america
University-of-houston

vimarsana © 2020. All Rights Reserved.